tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Holding RVNC?
Track your performance easily

Revance Therapeutics (RVNC) Cash flow

623 Followers

Revance Therapeutics Cash Flow

RVNC's free cash flow for Q3 2024 was $-41.15M. For the 2024 fiscal year, RVNC's free cash flow was decreased by $-26.70M and operating cash flow was $-41.09M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -190.89M$ -216.57M$ -193.55M$ -221.54M$ -178.50M$ -106.16M
Investing Cash Flow
$ -12.94M$ 109.74M$ -138.80M$ -29.66M$ 12.13M$ -17.59M
Financing Cash Flow
$ 81.70M$ 136.57M$ 331.69M$ 29.87M$ 331.48M$ 221.66M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 437.79M$ 144.75M$ 115.02M$ 115.67M$ 337.00M$ 171.89M
Income Tax Paid Supplemental Data
$ 300.00K$ 300.00K$ 700.00K-$ 100.00K$ 3.00M
Interest Paid Supplemental Data
$ 15.09M$ 15.09M$ 12.23M$ 5.03M$ 2.53M-
Issuance Of Capital Stock
-$ 100.18M$ 31.81M$ 21.71M$ 68.37M$ 10.87M
Issuance Of Debt
$ -16.58M$ 30.16M$ 87.05M-$ 278.31M-
Repayment Of Debt
$ -13.84M$ -18.25M$ -11.10M-$ -9.19M-
Free Cash Flow
$ -150.40M$ -223.46M$ -196.76M$ -231.91M$ -182.72M$ -109.39M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Revance Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis